Research uncovers new insights on ALS and points to a potentially promising treatment strategy
Blocking tau, a hallmark of Alzheimer’s disease, may benefit ALS patients.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Contact Information
Boston, MAPhone: 617-724-3914
Boston, MAPhone: 617-726-3642
Dr. Berry provides care for people with amyotrophic lateral sclerosis (ALS). He is the Winthrop Family Scholar in ALS Sciences, the Director of the Massachusetts General Hospital (MGH) multidisciplinary ALS clinic and Chief of the Division of ALS and Motor Neuron Diseases. He has worked to better serve people with ALS by building the tools and team required to extend the reach of the MGH clinic team beyond the walls of the physical clinic. The ALS House Call program and video televisit program are examples of exciting initiatives at the MGH ALS clinic.
Dr. Berry works as an ALS researcher, designing, overseeing, and carrying out trials at MGH and centers across the country. His work is focused on the identification of markers of ALS in blood and spinal fluid, with an emphasis on markers of abnormal inflammation. He collaborates broadly with researchers around the globe on these biomarker efforts. He is also actively working to develop mobile health and digital phenotyping methods to better understand ALS and hasten the development of new therapies, while reducing the burden of trial participation for people with ALS.
Dr. Berry is also the Director of the MGH Neurological Clinical Research Institute (NCRI) and Director of the Mass General Brigham Neurodegenerative Clinical Research Fellowship. He is a member of the Massachusetts ALS Registry team and CDC/ATSDR National ALS Registry and Biorepository Expert Panels. In addition, he is on the Executive Committee of the NEALS Consortium, a national organization for ALS clinical researchers, where he also leads the NEALS Biorepository and Technology in ALS subcommittee.
Clinical Interests:
Treats:
Sean M. Healey and AMG Center for ALS
55 Fruit Street
Wang Ambulatory Care Center
8th Floor
Boston, MA 02114
Phone: 617-724-3914
Mass General Neurology: Neuromuscular
165 Cambridge St.
Charles River Plaza
Suite 820
Boston, MA 02114
Phone: 617-726-3642
Medical Education
American Board Certifications
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Secure online access to your health information whenever you need it. Check appointments, communicate with your provider and pay bills online 24/7.
Mass General is the #1 Research Hospital in America and recognized in 14 specialties assessed by U.S. News & World Report.
Blocking tau, a hallmark of Alzheimer’s disease, may benefit ALS patients.
Friends and family of Healey Center for ALS patient Kathleen McCarron fielded a fundraising team for the 203-mile Bourbon Chase Ragnar Relay.
A team from sALSa for a Cure joined the ALSA Walk to Defeat ALS on October 19 and supported team member Kristen Vaughan in the 2019 New York City Marathon to raise money for ALS research at Mass General.
Two hundred people attended the “Olson it About Time to Cure ALS? Corn Hole Tournament on August 25th in honor of their friend, George Olson, a nationally recognized chemical engineer and former football player at Northeastern University who was diagnosed with ALS at the age of 54.
Announcing one of the most promising avenues for igniting a paradigm shift in ALS therapy development: the ALS platform trial.
Members of the Northeast Amyotrophic Lateral Sclerosis Consortium assembled at the Opal Sands Resort, in Clearwater, Florida on October 2nd through October 4th for their 18th Annual Scientific Symposium.